Atreca Current Ratio from 2010 to 2024

BCELDelisted Stock  USD 0.07  0.0005  0.70%   
Check Atreca financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Atreca main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . Atreca financial statements analysis is a perfect complement when working with Atreca Valuation or Volatility modules.
  
This module can also supplement various Atreca Technical models . Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.

About Atreca Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Atreca income statement, its balance sheet, and the statement of cash flows. Atreca investors use historical funamental indicators, such as Atreca's Current Ratio, to determine how well the company is positioned to perform in the future. Although Atreca investors may use each financial statement separately, they are all related. The changes in Atreca's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Atreca's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Atreca Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Atreca. Please read more on our technical analysis and fundamental analysis pages.
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Atreca, Inc. was incorporated in 2010 and is based in San Carlos, California. Atreca Inc operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 105 people.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Atreca in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Atreca's short interest history, or implied volatility extrapolated from Atreca options trading.

Pair Trading with Atreca

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Atreca position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Atreca will appreciate offsetting losses from the drop in the long position's value.

Moving against Atreca Pink Sheet

  0.52DOMH Dominari HoldingsPairCorr
  0.46VERU Veru Inc Buyout TrendPairCorr
  0.44VALN Valneva SE ADR Financial Report 2nd of May 2024 PairCorr
The ability to find closely correlated positions to Atreca could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Atreca when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Atreca - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Atreca Inc to buy it.
The correlation of Atreca is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Atreca moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Atreca Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Atreca can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income.
Note that the Atreca Inc information on this page should be used as a complementary analysis to other Atreca's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.

Other Consideration for investing in Atreca Pink Sheet

If you are still planning to invest in Atreca Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Atreca's history and understand the potential risks before investing.
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios